Introduction: Infections caused by multiple drug-resistant pathogens represent an increasingly often encountered challenge in clinical practice. The problem particularly applies to patients with chronic lung diseases resulting in multiple hospitalisations. The aim of this paper was to analyse the incidence of alert pathogens isolated from patients hospitalised in the department of lung diseases, who were divided into three groups: patients qualified for lung transplantation, patients treated for neoplastic diseases and patients with chronic lung diseases. 
Introduction
Infections caused by drug-resistant bacterial strains constitute a significant problem in patients hospitalised in the pulmonology departments. The necessity of frequent use of antibiotics and chemotherapeutic drugs in this group of patients increases resistance of microorganisms to the used drugs and consequently, leads to the appearance of multidrug-resistant strains [1−3] . Furthermore, it should be emphasised that there are more and more people with reduced resistance, who are exposed to infectious complications. It is related to an increased number of older patients with chronic diseases, who undergo lung transplantation and cytostatic treatment [4, 5] . Drug resistance of bacterial strains contributes to limited therapeutic possibilities, prolonged hospitalisations and consequently, a higher probability of failure of the applied treatment [5] [6] [7] [8] , and a considerable increase in hospitalisation costs [8, 9] . Supervisory programmes that control infections with alert pathogens focus on rapid methods of pathogens identification, implementation of correct procedures for the patient isolation and preparation of specialised therapeutic algorithms [5, 7, 10] .
The aim of the study was to analyse the prevalence of alert pathogens isolated from patients of the department of lung diseases divided into three groups: patients qualified for lung transplantation, patients treated for neoplastic diseases and patients treated for chronic lung diseases.
Material and methods
3950 clinical specimens were analysed (85% sputum, 3% urine, 2% blood) from 3521 patients of the pulmonology department, the Third Independent Public Teaching Hospital in Zabrze-Biskupice, hospitalised between 2007−2011.
Basing on clinical characteristics, patients were divided into three groups: -patients qualified for lung transplantation, -patients treated for neoplastic lung diseases, -patients treated for chronic lung diseases.
Microbiological diagnosis was conducted basing on applicable standards, collected material was cultured on proper solid or liquid media with their consecutive identification in semi-automatic system manufactured by BioMerieux Polska-Vitek; tests for drug resistance and identification of resistance mechanisms were carried out basing on standards defined in the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
200 specimens from the patients qualified for lung transplantation (5.7% of all specimens), 1292 specimens from patients with neoplasms (36.7% of all specimens) and 2029 from patients with chronic lung diseases (57.6% of all specimens).
The obtained data were analysed statistically. The significance of proportion differences was examined using z test. Significance of differences between the results was assumed at p < 0.05.
Results
During the analysed 5-year period 155 drug--resistant bacterial strains were isolated. In all www.pneumonologia.viamedica.pl groups of patients, most frequently isolated pathogen was P. aeruginosa, which accounted for 27% of all infections. Other pathogens in accordance with their prevalence were as follows: A. baumanii ESBL(−) (13%), S. pneumoniae (12%), E. cloacae ESBL(+) (10%), K. pneumoniae ESBL(+) (10%), S. aureus MRSA (8%), E. faecalis (7%), E. coli ESBL(+) (6%), S. maltophilia ESBL(+) (5%) and E. kobei ESBL(+) (2%). The results of analysis of the prevalence of particular strains during a 5-year period were presented in Figure 1 . 
Patients qualified for lung transplantation

Patients treated for lung neoplasms
In the group of 1292 patients treated for lung neoplasms, 35 alert pathogens were isolated (2.7%). Except for bacteria mentioned in the previous group of patients, there were also resistant strains of E. coli ESBL(+) and Gram (+) cocci, i.e. E. faecalis and S. pneumoniae (Table 2) . Similarly as in the first analysed group, the most frequent pathogen was P. aeruginosa, which was isolated from 28.6% of specimens. The proportion of fermenting bacilli from the Enterobacteriacae family was distinctly larger and it exceeded 31%, the most often isolated was Enterobacter cloacae ESBL(+), which constituted 14% of all isolates in the group. It should be emphasised that the proportion of Gram (+) cocci, including the proportion of pneumococci -S. pneumoniae, which is sensitive to penicillins, was clearly higher, compared to the previous group (1/3 of all isolated bacteria) and accounted for 14%. The proportion of MRSA was lower (8.5%).
Patients treated for chronic diseases of the respiratory system
In the group of patients treated for chronic diseases of the respiratory system, in 89 (4.4%) subjects out of 2029 hospitalised patients, at least one alert pathogen was isolated. In this group of patients, diverse species of isolated pathogens were found, with dominant P. aeruginosa, which was an aetiological factor of more than every fifth infection (22.5%), and S. pneumoniae, which is sensitive to penicillins (14.6%) ( Table 3 ). The www.pneumonologia.viamedica.pl In the presented material, in the group of patients with chronic diseases of the respiratory system and patients with neoplasms, infection with A. baumanii occurred more rarely than infection with S. pneumoniae: 8.57% and 14.29%, and 8.99% and 14.61% respectively. These results correspond with the researches carried out by other authors [11, 18, 21] .
Infection with S. pneumoniae was not found in the group of patients qualified for lung transplantation. Presumably, it is related to relatively lower resistance of the species to antibiotics [5, 10] . Gram (+) cocci -E. faecalis were not found in this group of patients either [18] .
Among the analysed pathogens, the Enterobacteriaceae were represented by: E. cloacae ESBL(+), K. pneumoniae ESBL(+), E. kobei ESBL(+) and E. coli ESBL(+) present in the material in the largest numbers in the group of patients with lung neoplastic diseases and in patients with chronic pulmonary pathology (31% and 30% respectively). Resistance of Enterobacteriaceae to antibiotics is a significant risk factor of prolonged hospitalisation [22] . In the analysed material, in patients qualified for lung transplantation, infections with pathogens from the Enterobacteriaceae family constituted 19%. According to the literature, K. pneumoniae is a pathogen that frequently constitutes an infectious agent in the early post-transplant period [23] .
According to the agency of the federal government of the United States -Centers for Disease Control and Prevention -methicillin-resistant S. aureus is becoming more and more frequently recognised infectious agent and the cause of deaths. In the United States, infections with MRSA cause more deaths than tuberculosis and AIDS combined [1] . Next to P. aeruginosa, MRSA is the most frequent factor of pneumonia and bronchitis among patients who underwent immunosuppression due to lung transplantation [16, 24] , which is in accordance with the results of the present study.
The last analysed pathogen was S. maltophilia ESBL(+). This non-fermenting Gram-negative bacillus is phylogenetically close to P. aeruginosa and it often colonises the airways of the patients with chronic lung diseases, in immunosuppression or treated for neoplasms. COPD patients and the persons who repeatedly undergo therapy with antibiotics, are at risk of colonisation with this bacterium. Its presence is associated with prolonged hospitalisation and increased patients' mortality and longer time of mechanical ventilation [6, 25] .
prevalence of the remaining pathogens in the group was well-balanced. A lower proportion of MRSA (5.6%), compared to the two previous groups was observed.
In the analysed groups, resistant strains were isolated significantly more often in patients qualified for transplantation (p < 0.01), compared to the remaining subjects. The group of patients with neoplasms and the group with chronic diseases of the respiratory system did not differ significantly in respect of proportions of patients infected with alert microorganisms.
Discussion
Alert pathogens made up a significant proportion of bacteria isolated from biological material of patients of the department of lung diseases. Among the isolated pathogens, P. aeruginosa prevailed. Currently, this pathogen is becoming the most frequent cause of infections worldwide, it is also changing into more and more resistant to the drugs such as quinolones, carbapenems and aminiglycosides [1] . P. aeruginosa is an aetiological factor of exacerbations of chronic lung diseases causing progressive impairment of functioning of the respiratory system expressed in lowered forced expiratory volume in 1 second (FEV 1 ) [11, 12] . Among patients with lowered immunity after lung transplantation, this pathogen is an aetiological factor of pneumonia, contributing to higher mortality in the early post-transplant period and at long-term follow-up. According to the authors who conducted the studies in Spain, approximately 24% of pneumonia cases after lung transplantation is caused by this pathogen [13−16] . Moreover, P. aeruginosa is frequently isolated in patients with neutropenic fever in the course of lung cancer chemotherapy [17, 18] .
The consecutive, in respect of frequency, pathogen isolated among patients qualified for lung transplantation was A. baumanii, which occurred comparably as often as P. aeruginosa (29% and 35% of infections respectively). The results of the published studies have shown that the colonisation of the airways with A. baumanii, and infection with this pathogen in the post-transplant period, constitute a risk factor of prolonged pneumonia in the group of patients after lung transplantation, and consequently, lead to pulmonary fibrosis with compensatory hyperinflation of a native lung [19, 20] . The recent studies have clearly shown that A. baumanii play a crucial role in the increase in mortality among patients infected with this pathogen [4] .
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To sum up, alert pathogens constitute a vital problem in the group of patients of the department of lung diseases. According to our data, the group most exposed to infections with these bacteria are patients qualified for lung transplantation. For infections influence long-term prognosis, their efficient therapy is crucial in all groups of patients. It should be emphasised that in the analysed material, there were no pathogens of most dangerous resistance mechanisms, i.e. K. pneumoniae KPC (+) producing beta lactamases active to carbapenems, Pseudomonas and Acinetobacter MBL(+) strains producing metallo beta lactamases or OXA-48 (+) producing oxacillinases that hydrolise carbapenems or vancomycin-resistant Enterococcus strains (VRE) or penicillin-resistant pneumococci.
Conclusions
Infection with alert pathogens affected 4% of patients hospitalised in the department of lung diseases. It occurred significantly more often in patients qualified for lung transplantation, compared to the remaining subjects. The pathogen that occurred in all study groups was P. aeruginosa (27% of all infections).
